| Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients. | |
| | |
MedLine Citation:
|
PMID: 16731299 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: The diagnostic power of the transferrin receptor-ferritin (TfR-F) index for identification of iron responsiveness in long-term hemodialysis (HD) patients compared with the routine markers recommended by the current US and European guidelines was appraised. METHODS: Initially, 121 long-term HD patients with a serum ferritin level less than 800 microg/L and on recombinant erythropoietin (rHuEPO) therapy for longer than 6 months were enrolled for intravenous iron (IVFE) supplementation (100 mg of iron polymaltose 3 times/wk for 4 weeks, then 100 mg every 2 weeks for 5 months). Routine iron tests (ie, serum ferritin and transferrin saturation [TSAT]), TfR-F index calculated by the ratio of soluble TfR to log ferritin level, hematocrit, hemoglobin, red blood cell count, and serum high-sensitive C-reactive protein were examined at baseline. Hematocrit and hemoglobin were followed up every 2 weeks during the study period. RESULTS: One hundred patients (52 men, 48 women; mean age, 59 years) completed this study. Fifty-two patients were IVFE responders, defined as an increase in hematocrit greater than 3% and/or a decrease in rHuEPO dose greater than 30% of baseline values at the end of the study, and 48 nonresponders did not fulfill these criteria. Of 52 responders, only 14 patients (27%) could be recognized for iron deficiency by means of routine iron tests (ferritin < 100 microg/L and/or TSAT < 20%). Thirty-three responders (63%) could be further identified for iron deficiency by using TfR-F index (> 0.6), but 5 (10%) still could not by either method. Analyses by using receiver operating characteristic (ROC) curves showed that a cutoff value greater than 0.6 for TfR-F index had greater sensitivity (90%) for the detection of iron deficiency than ferritin level less than 100 microg/L (29%) and TSAT less than 20% (6%). TfR-F index showed a greater area under the ROC curve than ferritin level (P < 0.05) and TSAT (P < 0.001). CONCLUSION: TfR-F index is superior to routine tests for predicting response to IVFE supplementation in long-term HD patients. Our study indicates that TfR-F index is a new and surrogate marker to estimate body iron stores and guide IVFE therapy for long-term HD patients. |
| | |
Authors:
|
Yen-Cheng Chen; Szu-Chun Hung; Der-Cherng Tarng |
Related Documents
:
|
8320949 - Does anemia correction by rhuepo improve uremic cardiopathy? 9360659 - More than 17 years of peritoneal dialysis: a case report. 18846269 - Methoxypolyethylene glycol-epoetin beta for the treatment of anemia associated with chr... 11341599 - Research on the best chemohyperthermia technique of treatment of peritoneal carcinomato... 18805609 - Associations of dialysis modality and infectious mortality in incident dialysis patient... 19635169 - Rationale and design of the oral heme iron polypeptide against treatment with oral cont... 22010409 - Influence of occlusal stabilization splints and soft occlusal splints on the electromyo... 23034729 - Final follow-up of the multicentre aneurysm screening study (mass) randomized trial of ... 21195429 - Intrahepatic radiofrequency ablation versus electrochemical treatment ex vivo. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: American journal of kidney diseases : the official journal of the National Kidney Foundation Volume: 47 ISSN: 1523-6838 ISO Abbreviation: Am. J. Kidney Dis. Publication Date: 2006 Jun |
Date Detail:
|
Created Date: 2006-05-29 Completed Date: 2006-06-09 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8110075 Medline TA: Am J Kidney Dis Country: United States |
Other Details:
|
Languages: eng Pagination: 1036-44 Citation Subset: IM |
Affiliation:
|
Institutes of Physiology and Clinical Medicine, Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Anemia, Iron-Deficiency / blood, diagnosis*, drug therapy, etiology Biological Markers / blood Biopsy Bone Marrow / pathology C-Reactive Protein / analysis Diagnostic Tests, Routine / methods, statistics & numerical data* Erythropoietin / administration & dosage, therapeutic use Female Ferritins / blood* Hematocrit Hemoglobins / analysis Humans Injections, Intravenous Kidney Failure, Chronic / blood, complications, drug therapy Male Middle Aged Predictive Value of Tests Prospective Studies Receptors, Transferrin / blood* Renal Dialysis / methods* Sensitivity and Specificity Time Factors |
| Chemical | |
Reg. No./Substance:
|
0/Biological Markers; 0/Hemoglobins; 0/Receptors, Transferrin; 11096-26-7/Erythropoietin; 9007-41-4/C-Reactive Protein; 9007-73-2/Ferritins |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Iron-replete hemodialysis patients do not require higher EPO dosages when converting from subcutaneo...
Next Document: Effects of efficiency and length of acetate-free biofiltration session on postdialysis solute reboun...